Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Estradiol Transdermal System |
Active Ingredient: | Estradiol hemihydrate 0.585mg equivalent to estradiol 37.5mcg/24 hours |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Sandoz New Zealand Limited |
Manufacturer: | Noven Pharmaceuticals Inc, Florida, United States of America |
Note: This consent is given subject to the following conditions:
|
|
Note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Estradiol Transdermal System |
Active Ingredient: | Estradiol hemihydrate 0.78mg equivalent to estradiol 50mcg/24 hours |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Sandoz New Zealand Limited |
Manufacturer: | Noven Pharmaceuticals Inc, Florida, United States of America |
Note: This consent is given subject to the following conditions:
|
|
Note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Estradiol Transdermal System |
Active Ingredient: | Estradiol hemihydrate 1.17mg equivalent to estradiol 75mcg/24 hours |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Sandoz New Zealand Limited |
Manufacturer: | Noven Pharmaceuticals Inc, Florida, United States of America |
Note: This consent is given subject to the following conditions:
|
|
Note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Estradiol Transdermal System |
Active Ingredient: | Estradiol hemihydrate 1.56mg equivalent to estradiol 100mcg/24 hours |
Dosage Form: | Transdermal patch |
New Zealand Sponsor: | Sandoz New Zealand Limited |
Manufacturer: | Noven Pharmaceuticals Inc, Florida, United States of America |
Note: This consent is given subject to the following conditions:
|
|
Note: This consent is valid for two years from the date of publication of this notice. |
Dated this 30th day of May 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).